50% off Premium Yearly
Procter & GamblePGDON'T BUYMar 12, 2026Stock price when the opinion was issued
As of Jun 18, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
He doesn't have a lot of $$ in consumer staples. Pretty low earnings growth of 4.5%. Input costs are rising. Slightly below 200-day MA, which is falling; technical structure not sound. 200-week also starting to round down.
See his Top Picks.